J. Virol., 11 1996, 7462-7470, Vol 70, No. 11
Copyright © 1996, American Society for Microbiology

Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface

H Hu, T Shioda, C Moriya, X Xin, MK Hasan, K Miyake, T Shimada and Y Nagai
Department of Viral Infection, Institute of Medical Science, University of Tokyo, Minato-ku, Japan.

The envelope protein, gp120, of human immunodeficiency virus type 1 (HIV-1) is heavily glycosylated and sialylated. The heavy sialylation greatly affects the physical properties of the protein, as it resolves into a wide acidic pH range despite the basic pI value predicted for its polypeptide backbone (B. S. Stein and E. G. Engleman, J. Biol. Chem. 265:2640-2649, 1990). However, the functional significance of the heavy sialylation remains elusive. Here, we show that desialylation of HIV-1 with neuraminidase greatly augments the initial virus-cell interaction, leading to remarkably enhanced viral replication and cytopathogenicity. This enhancement appeared to be a direct result of the removal of negatively charged sialic acids but not of the exposure of galactose residues or complement activation. Complementing these results, studies with inhibitors of mannosidase I and mannosidase II showed that the processing of HIV-1 oligosaccharides into the complex type to acquire the terminal sialic acid residues impeded the full replication capacity of the virus and that its prevention also enhanced virus replication and cytopathogenicity. Enhancement of infection by desialylation was found widely, with HIV-1 laboratory strains of different cell tropisms and primary isolates as well as HIV-2 and simian immunodeficiency virus. Thus, the sialylation catalyzed by host cell pathways appeared to reduce the infectivity of human and nonhuman primate lentiviruses. Our results further suggested that desialylation would help increase the titers of HIV-based vectors.

This article has been cited by other articles:

• Gaskill, P. J., Zandonatti, M., Gilmartin, T., Head, S. R., Fox, H. S. (2008). Macrophage-Derived Simian Immunodeficiency Virus Exhibits Enhanced Infectivity by Comparison with T-Cell-Derived Virus. J. Virol. 82: 1615-1621 [Abstract] [Full Text]  
• Teuton, J. R., Brandt, C. R. (2007). Sialic Acid on Herpes Simplex Virus Type 1 Envelope Glycoproteins Is Required for Efficient Infection of Cells. J. Virol. 81: 3731-3739 [Abstract] [Full Text]  
• Delputte, P. L., Nauwynck, H. J. (2004). Porcine Arterivirus Infection of Alveolar Macrophages Is Mediated by Sialic Acid on the Virus. J. Virol. 78: 8094-8101 [Abstract] [Full Text]  
• Sun, J., Barbeau, B., Sato, S., Boivin, G., Goyette, N., Tremblay, M. J. (2002). Syncytium Formation and HIV-1 Replication Are Both Accentuated by Purified Influenza and Virus-associated Neuraminidase. J. Biol. Chem. 277: 9825-9833 [Abstract] [Full Text]  
• Mori, K., Yasutomi, Y., Ohgimoto, S., Nakasone, T., Takamura, S., Shioda, T., Nagai, Y. (2001). Quintuple Deglycosylation Mutant of Simian Immunodeficiency Virus SIVmac239 in Rhesus Macaques: Robust Primary Replication, Tightly Contained Chronic Infection, and Elicitation of Potent Immunity against the Parental Wild-Type Strain. J. Virol. 75: 4023-4028 [Abstract] [Full Text]  
• Means, R. E., Desrosiers, R. C. (2000). Resistance of Native, Oligomeric Envelope on Simian Immunodeficiency Virus to Digestion by Glycosidases. J. Virol. 74: 11181-11190 [Abstract] [Full Text]  
• Ohgimoto, S., Shioda, T., Mori, K., Nakayama, E. E., Hu, H., Nagai, Y. (1998). Location-Specific, Unequal Contribution of the N Glycans in Simian Immunodeficiency Virus gp120 to Viral Infectivity and Removal of Multiple Glycans without Disturbing Infectivity. J. Virol. 72: 8365-8370 [Abstract] [Full Text]